Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Jul
6
2016
Federal Circuit Rules Biosimilar Notice of Commercial Marketing Mandatory Michael Best & Friedrich LLP
Jul
6
2016
Supreme Court Gives Deference to USPTO in Post Grant Proceedings Hunton Andrews Kurth
Jul
6
2016
Apotex—Biosimilars Must Provide 180-Day Marketing Notice After FDA Approval Morgan, Lewis & Bockius LLP
Jul
6
2016
Focusing on Second Step of Alice, Federal Circuit Finds Inventive Concept in Software Patent in BASCOM Mintz
Jul
6
2016
PTO Litigation Center Report – July 6, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
6
2016
Federal Circuit's Primer on Patent-Eligibility in Rapid Litig. v. CellzDirect Foley & Lardner LLP
Jul
6
2016
Fed Circuit’s “Amgen v. Apotex” Decision: Clarification of BPCIA Riddle (Unless, of course, Supreme Court Steps In) Mintz
Jul
6
2016
Federal Circuit Requires 180 Day Notice For All Biosimilars, Even After Patent Dance Foley & Lardner LLP
Jul
5
2016
Rapid Litigation v. CellzDirect – A Break in the Section 101 Wall Schwegman, Lundberg & Woessner, P.A.
Jul
5
2016
BASCOM—Federal Circuit Holds Internet Content Filtering Patent Passes Alice Test Morgan, Lewis & Bockius LLP
Jul
5
2016
Bascom v. AT&T — Patent Eligibility Meet Patentability Schwegman, Lundberg & Woessner, P.A.
Jul
5
2016
PTO Litigation Center Report – July 5, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
5
2016
Supreme Court Declines Sequenom Review Foley & Lardner LLP
Jul
1
2016
No Approval for Generic Product for Treatment of Rosacea McDermott Will & Emery
Jul
1
2016
Administrative Law Judge Lord Grants Another Summary Determination of Section 101 Invalidity Squire Patton Boggs (US) LLP
Jul
1
2016
PTAB Provides Procedural Guidance, Designates Five Opinions as Precedential McDermott Will & Emery
Jul
1
2016
PTO Litigation Center Report – July 1, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
1
2016
PTAB Still Divided Over What Patents Qualify for CBM Review McDermott Will & Emery
Jul
1
2016
Saying It YOUR Way, On THEIR Website: Not a Registrable Service Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
1
2016
PTAB Grants Late Motion to Amend, But Amended Claims Fail to Breathe Life into Patent McDermott Will & Emery
Jun
30
2016
“Churrascos” Is Generic for Restaurant Services McDermott Will & Emery
Jun
30
2016
Trademark Dilution Update: NYC BEER Is Not Diluted, But The Empire State Building Is Mintz
Jun
30
2016
PTO Litigation Center Report – June 30, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
30
2016
Intrinsic Feature in All Described Embodiments Makes Patent Claim Insurmountable McDermott Will & Emery
Jun
30
2016
When Distinguishing Statements May Be Considered Disclaimers of Patent Claim Scope McDermott Will & Emery
Jun
30
2016
Look to Specification to Interpret Facially Unclear Patent Claims: Howmedica Osteonics v. Zimmer McDermott Will & Emery
Jun
30
2016
In Patents, Narrow Construction May Apply When No Evidence Supports Broader Construction McDermott Will & Emery
Jun
30
2016
Inter Partes Review Institution Decisions Not Appealable, Broadest Reasonable Interpretation Remains Standard McDermott Will & Emery
Jun
29
2016
Federal Circuit Distinguishes “Motivation to Combine” from “Expectation of Success” for Obviousness Purposes McDermott Will & Emery
Jun
29
2016
Supreme Court Holds that Decision to Institute IPR is Non-appealable and PTAB’s “Broadest Reasonable Construction” Standard for Claim Construction is Lawful ArentFox Schiff LLP
Jun
29
2016
Binding Contract or Completed Sale Not Necessary to Raise On-Sale Bar McDermott Will & Emery
Jun
29
2016
Evolving Patent Eligibility Standard for Computer-Implemented Inventions McDermott Will & Emery
Jun
29
2016
Another Unregistrable Trademark Surname: DICKMAN’S Pickles Mintz
Jun
29
2016
PTO Litigation Center Report – June 29, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
28
2016
Trademarks Confusion: MAYA And MAYARI Are Not Confusingly Similar When Used On Wine Mintz
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters